Goldman Sachs & Co. LLC

New York, NY Finance & insuranceNAICS 523110

Self-funded health planPlan year 2025Renews January
46,265Participants+3% vs. prior year
$109.7MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#1 of 59Finance & insurance in NYBy participants

Overview

Goldman Sachs & Co. LLC sponsors a self-funded health plan that covered 46,265 participants in plan year 2025, up 3% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
46,265 · prior year 45,014
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Goldman Sachs & Co. LLC Health & Welfare Plan, plan 501 (46,265 participants); Retiree Health Care Plan, plan 502 (1,199 participants)
Broker compensation
$1.9M across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Aetna Life Insurance CompanyMedical, Prescription drug, PPO1,327$50.7M—
Metropolitan Life Insurance CompanyLife, Vision28,235$15.1M$232K
The Prudential Insurance Company of AmericaShort-term disability, Life, Long-term disability23,939$6.8M$184K
Provident Life and Casualty Insurance CompanyLong-term disability1,423$2.9M$881K
Cigna Health and Life Insurance Company and AffiliatesDental, HMO8,411$2.7M—
Aetna Global BenefitsMedical, Prescription drug, PPO221$2.6M—
Cigna Health and Life InsuranceDental, HMO1,595$2.3M—
Provident Life and Accident Insurance CompanyLong-term disability397$1.5M$408K
National Union Fire Ins. Co. of Pittsburgh, PALife43,926$587K$88K
Metropolitan General Insurance CompanyLegal2,774$586K$70K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$109.7M/ year

Estimated prescription spend: 46,265 participants × $2,371 national average per member. Usually higher once dependents are counted.

$2.9M–$7.0M/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$834K–$2.1M
Lower-cost therapeutic alternatives$1.2M–$2.5M
Generic pricing vs. actual cost$527K–$1.6M
PBM contract terms$274K–$823K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Goldman Sachs & Co. LLC
Sponsor EIN
13-5108880
Plan numbers
501, 502
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 13-5108880 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Goldman Sachs & Co. LLC's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Goldman Sachs & Co. LLC.

Request a correction · Methodology